19 April 2024 Scandion Oncology – Notice convening the Annual General Meeting Download Presentation Webcast Workbook
15 December 2023 Scandion Oncology identifies potentially effective treatment of gastric cancer Download Presentation Webcast Workbook
29 November 2023 Scandion Oncology is granted new Composition of Matter-patent on lead compound SCO-101 extending its exclusivity until at least 2042 Download Presentation Webcast Workbook
15 November 2023 Invitation to Scandion Oncology webcast and conference call November 22, 2023 Download Presentation Webcast Workbook
16 October 2023 Phase Ib PANTAX trial is successfully completed and establishes the maximal tolerated dose with positive safety profile and pharmacokinetic data. Download Presentation Webcast Workbook
17 August 2023 Data from PANTAX trial to be presented at ESMO Congress 2023 Download Presentation Webcast Workbook
16 August 2023 Invitation to Scandion Oncology webcast and conference call August 23, 2023 Download Presentation Webcast Workbook